APA (7th ed.) Citation

Wu, J., Wang, D., Wang, Z., Li, Q., Xu, B., Ren, C., . . . Yang, H. (2026). Sintilimab plus cisplatin and nab‐paclitaxel induction treatment for locally advanced borderline‐resectable oesophageal squamous cell carcinoma: A single‐arm, prospective, phase 2 study (NEOCRTEC2001). Clinical & Translational Medicine, 16(5), 1. https://doi.org/10.1002/ctm2.70691

Chicago Style (17th ed.) Citation

Wu, Jia‐Di, et al. "Sintilimab Plus Cisplatin and Nab‐paclitaxel Induction Treatment for Locally Advanced Borderline‐resectable Oesophageal Squamous Cell Carcinoma: A Single‐arm, Prospective, Phase 2 Study (NEOCRTEC2001)." Clinical & Translational Medicine 16, no. 5 (2026): 1. https://doi.org/10.1002/ctm2.70691.

MLA (9th ed.) Citation

Wu, Jia‐Di, et al. "Sintilimab Plus Cisplatin and Nab‐paclitaxel Induction Treatment for Locally Advanced Borderline‐resectable Oesophageal Squamous Cell Carcinoma: A Single‐arm, Prospective, Phase 2 Study (NEOCRTEC2001)." Clinical & Translational Medicine, vol. 16, no. 5, 2026, p. 1, https://doi.org/10.1002/ctm2.70691.